Clinical Trial: A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003178) titled 'A Study to Evaluate the Safety and Clinical Efficacy of STR-P004' on May 19.

Brief Summary: This study is a single-arm, single-center, open-label, multiple-dose, dose-escalation early clinical study aimed at evaluating the safety, tolerability, and pharmacokinetic profile of STR-P004 in subjects with relapsed/refractory CD19-positive B-cell non-Hodgkin lymphoma, and preliminarily observing its antitumor activity.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Non Hodgkin Lymphoma

Intervention: DRUG: STR-P004

An in vivo CART drug administered intravenously

Recruitment Status: NOT_YET_RECRUITING

Sponsor: St...